# generate_tests\Test mAB\IgG2-K-002.txt
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Trypsin - 50%
GLEWIGYIYYSGSTYYNPSLK
VTISVDTSK
ESVAGFDYWGQGTLVTVSSASTK
CCVECPPCPAPPVAGPSVFLFPPKPK
TPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAK
EEQFNSTFR
VVSVLTVVHQDWLNGK
GLPAPIEK
EPQVYTLPPSR
TTPPMLDSDGSFFLYSK
WQQGNVFSCSVMHEALHNHYTQK
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Chymotrypsin - 50%
QESGPGL
VKPSQTL
KSRVTISVDTSKNQF
SSVTAADTAVY
APCSRSTSESTAAL
TSGVHTF
PPKPKDTL
VDGVEVHNAKTKPREEQF
RVVSVL
PAPIEKTISKTKGQPREPQVY
PPSREEM
TKNQVSL
PSDIAVEW
ESNGQPENNY
KTTPPM
DSDGSF
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Aspecific - 50%
LQESGPGLVKPSQTLS
VKPSQTL
VSGGSISSGEYYWNWIRQHPGKGLEWIGYI
SISSGEYYWNWIRQHPGKGLEWIGYIYY
SGEYYWNWIRQHPGKGLEWI
YYWNWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTI
WNWIRQHPGKGLEWIGYIYYSGSTYY
GLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQF
GSTYYNPSL
SLKSRVTISVDTSKNQFSLKLSSVTA
ISVDTSKNQFS
SVDTSKNQFSLKLSSV
FSLKLSSVTAADTAVYYCARESVAGFDYWGQGTLVTV
TAVYYCARESVAGFDYWGQGTLVTVSSASTKGPS
RESVAGFDYWGQGTLVTVSSASTKG
VAGFDYWGQGTLVTVSSASTKGPSV
TVSSASTKGPS
SESTAALGCLVKDYFPEPVTVSWN
NSGALTSGVHTFPAVLQSSGLYSLS
HTFPAVLQSSGLYSLSSVVTVPSSNF
PAVLQSSGLYSLSSVVTV
SVVTVPSSNFGTQTY
VPSSNFGTQTYTCNVDH
SNFGTQT
YTCNVDHKPS
YTCNVDHKPSNTKVDKTVERKCCVECP
VDHKPSNTKVDKTVERKCCVEC
SNTKVDKTVERKCCVECPPCPAPPVAGPS
TKVDKTVERKCCVECPPCPAP
RKCCVECPPCPAPPV
RKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPE
CPAPPVAGPSVFLFPPKP
PSVFLFPPK
MISRTPEVTCVVVDVSHEDPEVQFNWY
VDVSHEDPEVQFNWYVDGVEVHN
DVSHEDPEVQFNWYVDGVEVHNAKTK
VSHEDPEVQFNWYVDGVEVHNAKTKPREEQFN
PEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVH
QFNWYVDGVEVHNAKTKPREEQFNSTF
FNWYVDGVEVHNAKTKPREEQFNST
NWYVDGVEVHNAKTKPR
YVDGVEVHNAKTKPREEQ
AKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSN
RVVSVLTVVHQDWLNGKEYKCKVS
VHQDWLNGKEYKCKVSNK
HQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREP
YPSDIAVEWESNGQPENNYKTTPPMLDS
PSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLT
NNYKTTPPMLDSDGSFFLYSK
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - Trypsin - 50%
EIVLTQSPGTLSLSPGER
ASQSVSSSYLAWYQQKPGQAPR
FSGSGSGTDFTLTISR
LEPEDFAVYYCQQYGSSPITFGQGTR
TVAAPSVFIFPPSDEQLK
DSTYSLSSTLTLSK
VYACEVTHQGLSSPVTK
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - Chymotrypsin - 50%
TQSPGTL
SCRASQSVSSSY
QQKPGQAPRL
GQGTRL
EIKRTVAAPSVF
PPSDEQL
PREAKVQW
KVDNAL
QSGNSQESVTEQDSKDSTY
ACEVTHQGL
SSPVTKSF
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - Aspecific - 50%
QSPGTLSLSPGERATLSCRA
SPGTLSLSP
TLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQ
TLSCRASQSVSS
TLSCRASQSVSSSYLAWYQ
YLAWYQQKPGQAPR
KPGQAPRLLIYGTSSRATGIPDRFSGSG
FSGSGSG
PEDFAVYYCQQYGSSPITFGQGTRLEIKRTVAAP
AVYYCQQ
YCQQYGSSPITFGQGTRLEIKRTVAAPSVF
SPITFGQGTRLEIKRTVAAPSVFIFPP
VAAPSVFIFPPSDEQ
FPPSDEQLKSGTASVVCLLNNFYPREAKVQWKV
QDSKDSTYSLSSTLTLSKADYEKHKV
STYSLSSTLTLSKADYEK
SLSSTLTLSKADYEKHKVYACEV
VYACEVTHQGLSSPVTKS
